Zoetis Inc Stock Fundamentals

ZOE Stock  EUR 164.56  3.70  2.20%   
Zoetis Inc fundamentals help investors to digest information that contributes to Zoetis' financial success or failures. It also enables traders to predict the movement of Zoetis Stock. The fundamental analysis module provides a way to measure Zoetis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zoetis stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Zoetis Inc Company Shares Outstanding Analysis

Zoetis' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Zoetis Shares Outstanding

    
  463.39 M  
Most of Zoetis' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zoetis Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Zoetis Inc has 463.39 M of shares currently outstending. This is 156.68% higher than that of the Healthcare sector and 15.38% higher than that of the Drug Manufacturers - Specialty & Generic industry. The shares outstanding for all Germany stocks is 18.96% higher than that of the company.

Zoetis Inc Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Zoetis's current stock value. Our valuation model uses many indicators to compare Zoetis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zoetis competition to find correlations between indicators driving Zoetis's intrinsic value. More Info.
Zoetis Inc is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about  0.27  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Zoetis Inc is roughly  3.71 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zoetis' earnings, one of the primary drivers of an investment's value.

Did you try this?

Run Competition Analyzer Now

   

Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module

Zoetis Fundamentals

About Zoetis Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Zoetis Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zoetis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zoetis Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. ZOETIS INC operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10000 people.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Zoetis Stock

When determining whether Zoetis Inc is a strong investment it is important to analyze Zoetis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zoetis' future performance. For an informed investment choice regarding Zoetis Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zoetis Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Please note, there is a significant difference between Zoetis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zoetis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zoetis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.